• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Nanoparticles in Biotechnology and Pharmaceuticals Market

Global Nanoparticles in Biotechnology and Pharmaceuticals Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

  • Published Date : 19 Apr 2019
  • QY Research
  • Category : Medical Devices
  • Pages : 154

Summary

Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules
The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology. 
Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.
The global Nanoparticles in Biotechnology and Pharmaceuticals market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2019 and 2025.

This report studies the Nanoparticles in Biotechnology and Pharmaceuticals market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Nanoparticles in Biotechnology and Pharmaceuticals in these regions, from 2014 to 2025, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
    South America (Brazil etc.)
    Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
    Roche
    GE Healthcare
    Merck
    Novartis
    AMAG Pharmaceuticals
    Amgen
    Bausch & Lomb
    Biogen
    Celgene
    Gilead
    Ipsen
    Leadiant Biosciences
    nanoComposix
    Pacira Pharmaceuticals
    Pfizer
    Shire
By the product type, the market is primarily split into
    Fullerenes
    Liquid Crystals
    Liposomes
    Nanoshells
    Quantum dots
    Superparamagnetic nanoparticles
By the end users/application, this report covers the following segments
    Biotechnology
    Pharmaceutical

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa
        Rest of Middle East & Africa

The study objectives of this report are:
    To study and analyze the global Nanoparticles in Biotechnology and Pharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Nanoparticles in Biotechnology and Pharmaceuticals market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Nanoparticles in Biotechnology and Pharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Nanoparticles in Biotechnology and Pharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Nanoparticles in Biotechnology and Pharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nanoparticles in Biotechnology and Pharmaceuticals are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million USD) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nanoparticles in Biotechnology and Pharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Nanoparticles in Biotechnology and Pharmaceuticals market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.	
Table of Contents

1 Nanoparticles in Biotechnology and Pharmaceuticals Market Overview
    1.1 Nanoparticles in Biotechnology and Pharmaceuticals Product Overview
    1.2 Nanoparticles in Biotechnology and Pharmaceuticals Market Segment by Type
        1.2.1 Fullerenes
        1.2.2 Liquid Crystals
        1.2.3 Liposomes
        1.2.4 Nanoshells
        1.2.5 Quantum dots
        1.2.6 Superparamagnetic nanoparticles
    1.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size by Type
        1.3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth by Type
        1.3.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Type (2014-2019)
        1.3.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Type (2014-2019)
        1.3.4 Global Nanoparticles in Biotechnology and Pharmaceuticals Price by Type (2014-2019)

2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Competition by Company
    2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Company (2014-2019)
    2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Share by Company (2014-2019)
    2.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Price by Company (2014-2019)
    2.4 Global Top Players Nanoparticles in Biotechnology and Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types
    2.5 Nanoparticles in Biotechnology and Pharmaceuticals Market Competitive Situation and Trends
        2.5.1 Nanoparticles in Biotechnology and Pharmaceuticals Market Concentration Rate
        2.5.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share of Top 5 and Top 10 Players
        2.5.3 Mergers & Acquisitions, Expansion

3 Nanoparticles in Biotechnology and Pharmaceuticals Company Profiles and Sales Data
    3.1 Roche
        3.1.1 Company Basic Information, Manufacturing Base and Competitors
        3.1.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.1.3 Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.1.4 Main Business Overview
    3.2 GE Healthcare
        3.2.1 Company Basic Information, Manufacturing Base and Competitors
        3.2.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.2.3 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.2.4 Main Business Overview
    3.3 Merck
        3.3.1 Company Basic Information, Manufacturing Base and Competitors
        3.3.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.3.3 Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.3.4 Main Business Overview
    3.4 Novartis
        3.4.1 Company Basic Information, Manufacturing Base and Competitors
        3.4.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.4.3 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.4.4 Main Business Overview
    3.5 AMAG Pharmaceuticals
        3.5.1 Company Basic Information, Manufacturing Base and Competitors
        3.5.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.5.3 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.5.4 Main Business Overview
    3.6 Amgen
        3.6.1 Company Basic Information, Manufacturing Base and Competitors
        3.6.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.6.3 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.6.4 Main Business Overview
    3.7 Bausch & Lomb
        3.7.1 Company Basic Information, Manufacturing Base and Competitors
        3.7.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.7.3 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.7.4 Main Business Overview
    3.8 Biogen
        3.8.1 Company Basic Information, Manufacturing Base and Competitors
        3.8.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.8.3 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.8.4 Main Business Overview
    3.9 Celgene
        3.9.1 Company Basic Information, Manufacturing Base and Competitors
        3.9.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.9.3 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.9.4 Main Business Overview
    3.10 Gilead
        3.10.1 Company Basic Information, Manufacturing Base and Competitors
        3.10.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
        3.10.3 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin(2014-2019)
        3.10.4 Main Business Overview
    3.11 Ipsen
    3.12 Leadiant Biosciences
    3.13 nanoComposix
    3.14 Pacira Pharmaceuticals
    3.15 Pfizer
    3.16 Shire

4 Nanoparticles in Biotechnology and Pharmaceuticals Market Status and Outlook by Regions
    4.1 Global Market Status and Outlook by Regions
        4.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size and CAGR by Regions
        4.1.2 North America
        4.1.3 Asia-Pacific
        4.1.4 Europe
        4.1.5 South America
        4.1.6 Middle East and Africa
    4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue by Regions
        4.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Regions (2014-2019)
        4.2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Market Share by Regions (2014-2019)
        4.2.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
    4.3 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin
        4.3.1 United States
        4.3.2 Canada
        4.3.3 Mexico
    4.4 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin
        4.4.1 Germany
        4.4.2 UK
        4.4.3 France
        4.4.4 Italy
        4.4.5 Russia
        4.4.6 Turkey
    4.5 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin
        4.5.1 China
        4.5.2 Japan
        4.5.3 Korea
        4.5.4 Southeast Asia
            4.5.4.1 Indonesia
            4.5.4.2 Thailand
            4.5.4.3 Malaysia
            4.5.4.4 Philippines
            4.5.4.5 Vietnam
        4.5.5 India
        4.5.6 Australia
    4.6 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin 
        4.6.1 Brazil
    4.7 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue, Price and Gross Margin
        4.7.1 Egypt
        4.7.2 GCC Countries

5 Nanoparticles in Biotechnology and Pharmaceuticals Application/End Users
    5.1 Nanoparticles in Biotechnology and Pharmaceuticals Segment by Application
        5.1.1 Biotechnology
        5.1.2 Pharmaceutical
    5.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Product Segment by Application
        5.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales by Application
        5.2.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Market Share by Application (2014-2019)

6 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast
    6.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales, Revenue Forecast (2019-2025)
        6.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Growth Rate Forecast (2019-2025)
        6.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate Forecast (2019-2025)
    6.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Forecast by Regions
        6.2.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025)
        6.2.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025)
        6.2.3 Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025)
            6.2.3.1 China
            6.2.3.2 Japan
            6.2.3.3 Korea
            6.2.3.4 Southeast Asia
            6.2.3.5 India
            6.2.3.6 Australia
        6.2.4 South America Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025)
        6.2.5 Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast (2019-2025)
            6.2.5.1 Egypt
            6.2.5.2 GCC Countries
    6.3 Nanoparticles in Biotechnology and Pharmaceuticals Forecast by Type
        6.3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales and Revenue Forecast by Type (2019-2025)
        6.3.2 Fullerenes Gowth Forecast
        6.3.3 Liquid Crystals Gowth Forecast
    6.4 Nanoparticles in Biotechnology and Pharmaceuticals Forecast by Application
        6.4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Application (2019-2025)
        6.4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Forecast in Biotechnology
        6.4.3 Global Nanoparticles in Biotechnology and Pharmaceuticals Forecast in Pharmaceutical

7 Nanoparticles in Biotechnology and Pharmaceuticals Upstream Raw Materials
    7.1 Nanoparticles in Biotechnology and Pharmaceuticals Key Raw Materials
        7.1.1 Key Raw Materials
        7.1.2 Key Raw Materials Price
        7.1.3 Raw Materials Key Suppliers 
    7.2 Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Nanoparticles in Biotechnology and Pharmaceuticals Industrial Chain Analysis

8 Marketing Strategy Analysis, Distributors
    8.1 Marketing Channel
        8.1.1 Direct Marketing
        8.1.2 Indirect Marketing
        8.1.3 Marketing Channel Development Trend
    8.2 Distributors
    8.3 Downstream Customers

9 Research Findings and Conclusion

Appendix
    Methodology/Research Approach
        Research Programs/Design
        Market Size Estimation
        Market Breakdown and Data Triangulation
    Data Source
        Secondary Sources
        Primary Sources
    Disclaimer

	List of Tables and Figures

    Figure Nanoparticles in Biotechnology and Pharmaceuticals Product Picture
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) Status and Outlook (2014-2025)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Status and Outlook (2014-2025)
    Figure Product Picture of Fullerenes
    Table Major Players of Fullerenes
    Figure Global Fullerenes Sales (MT) and Growth Rate (%)(2014-2018)
    Figure Product Picture of Liquid Crystals
    Table Major Players of Liquid Crystals
    Figure Global Liquid Crystals Sales (MT) and Growth Rate (%)(2014-2019)
    Figure Product Picture of Liposomes
    Table Major Players of Liposomes
    Figure Global Liposomes Sales (MT) and Growth Rate (%)(2014-2019)
    Figure Product Picture of Nanoshells
    Table Major Players of Nanoshells
    Figure Global Nanoshells Sales (MT) and Growth Rate (%)(2014-2019)
    Figure Product Picture of Quantum dots
    Table Major Players of Quantum dots
    Figure Global Quantum dots Sales (MT) and Growth Rate (%)(2014-2019)
    Figure Product Picture of Superparamagnetic nanoparticles
    Table Major Players of Superparamagnetic nanoparticles
    Figure Global Superparamagnetic nanoparticles Sales (MT) and Growth Rate (%)(2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Comparison by Type
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) by Type (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share (%) by Type (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Type (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Type in 2018
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) by Type (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share (%) by Type (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share (%) by Type (2014-2019)
    Figure 2018 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) by Type
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Price (USD/Kg) by Type (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) by Company (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share (%) by Company (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share (%) by Company in 2018
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) by Company (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share (%) by Company (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Share (%) by Company in 2018
    Table Global Market Nanoparticles in Biotechnology and Pharmaceuticals Average Price (USD/Kg) by Company (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Top Players Manufacturing Base Distribution and Sales Area
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Top Players Product Category
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share (%) of Top 5 Players
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Market Share (%) of Top 10 Players
    Table Roche Basic Information List
    Table Roche Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure Roche Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table GE Healthcare Basic Information List
    Figure GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table Merck Basic Information List
    Figure Merck Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure Merck Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table Novartis Basic Information List
    Figure Novartis Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure Novartis Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table AMAG Pharmaceuticals Basic Information List
    Figure AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table Amgen Basic Information List
    Figure Amgen Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure Amgen Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table Bausch & Lomb Basic Information List
    Figure Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table Biogen Basic Information List
    Figure Biogen Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure Biogen Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table Celgene Basic Information List
    Figure Celgene Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure Celgene Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table Gilead Basic Information List
    Figure Gilead Nanoparticles in Biotechnology and Pharmaceuticals Product Category, Application and Specification
    Table Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate (2014-2019)
    Figure Gilead Nanoparticles in Biotechnology and Pharmaceuticals Sales Global Market Share (%)(2014-2019)
    Table Ipsen Basic Information List
    Table Leadiant Biosciences Basic Information List
    Table nanoComposix Basic Information List
    Table Pacira Pharmaceuticals Basic Information List
    Table Pfizer Basic Information List
    Table Shire Basic Information List
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size Comparison by Regions (2014-2025)
    Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025)
    Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025)
    Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025)
    Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025)
    Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%)(2014-2025)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) by Regions (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Regions (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Regions (2014-2019)
    Figure 2018 Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Regions
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) by Regions (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) by Regions (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) by Regions (2014-2019)
    Figure 2018 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) by Regions
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate
    Table North America Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure United States Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure United States Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Canada Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Canada Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Mexico Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Mexico Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate
    Table Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Germany Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Germany Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) (2014-2019)
    Figure UK Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure UK Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure France Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure France Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Italy Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Italy Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Russia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Russia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Turkey Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Turkey Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate
    Table Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure China Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Indonesia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Indonesia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Thailand Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Thailand Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Malaysia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Malaysia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Philippines Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Philippines Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Vietnam Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Vietnam Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure India Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure India Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Australia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Australia Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate
    Table South America Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure Brazil Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure Brazil Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales Growth Rate
    Table Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2014-2019)
    Figure North Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure North Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure GCC Countries Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT)(2014-2019)
    Figure GCC Countries Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD)(2014-2019)
    Figure Biotechnology Examples
    Figure Pharmaceutical Examples
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Comparison by Application (2014-2025)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) by Application (2014-2019)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Share (%) by Application (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Application (2014-2019)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) by Application in 2018
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Forecast by Regions (2019-2025)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) Forecast by Regions (2019-2025)
    Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure Asia-Pacific Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure China Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure China Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure Japan Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure Korea Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure India Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure India Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure Australia Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure Australia Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure South America Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure Middle East and Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure North Africa Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure North Africa Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Figure GCC Countries Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) and Growth Rate (%) Forecast (2019-2025)
    Figure GCC Countries Nanoparticles in Biotechnology and Pharmaceuticals Revenue and Growth Rate (%) Forecast (2019-2025)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (Million USD) Forecast by Type (2019-2025)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Share (%) Forecast by Type (2019-2025)
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (Million USD) Forecast by Type (2019-2025)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue Market Share (%) Forecast by Type (2019-2025)
    Figure Fullerenes Sales Growth Forecast
    Figure Liquid Crystals Sales Growth Forecast
    Table Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Forecast by Application (2019-2025)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Forecast by Application (2019-2025)
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Forecast in Biotechnology
    Figure Global Nanoparticles in Biotechnology and Pharmaceuticals Sales (MT) Forecast in Pharmaceutical
    Table Key Raw Materials Lists
    Figure Key Raw Materials Price
    Table Raw Materials Key Suppliers Lists 
    Figure Nanoparticles in Biotechnology and Pharmaceuticals Manufacturing Cost Structure
    Figure Nanoparticles in Biotechnology and Pharmaceuticals Industrial Chain Analysis
    Table Distributors List
    Table Nanoparticles in Biotechnology and Pharmaceuticals Downstream Customers

Related Reports

Emergency-X-ray-Machine-Market

Global Emergency X-ray Machine Market Research Report 2019-2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Emergency X-ray Machine Report by Material, and Geography – Global F ...read more

Osteosynthesis-Devices-Market

Global Osteosynthesis Devices Market Research Report 2019-2023

Osteosynthesis is the reduction and internal fixation of a bone fracture with implantable devices that are usually made of metal. In the context of China-US trade war and global economic volatility an ...read more

Wireless-Portable-Medical-Device-Market

Global Wireless Portable Medical Device Market Research Report 2019-2023

Wireless Portable Medical Device are medical devices with wireless technologies and easy to carry. In the context of China-US trade war and global economic volatility and uncertainty, it will have a b ...read more

Vein-Illumination-Devices-Market

Global Vein Illumination Devices Market Research Report 2019-2023

Vein illumination device is a biomedical device which uses near infrared light to illuminate subcutaneous veins on skin surface. In the context of China-US trade war and global economic volatility and ...read more

Apheresis-Equipment-Market

Global Apheresis Equipment Market Research Report 2019-2023

An apheresis machine is a device which receives blood removed from a patient or donor’s body. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Intel Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.